Skip to main content
The driveway to the Kay Jewelers Pavilion on our Akron Campus will be closed for 2-4 weeks beginning Oct. 10. Click HERE for details.
Go to homepage

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia COG AAML1331

Safety and Efficacy of Tretinoin and Arsenic Trioxide in Patients With Untreated Acute PML

Description:

For complete information, please visit the study on clinicaltrials.gov

Interested in participating?
We are currently recruiting
Study Sponsor:

Children's Oncology Group

Full IRB Study Title:
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-trans Retinoic Acid
IRB Study ID:
1099169
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research and Stem Cell Transplantation; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program